Literature DB >> 16686604

Differential role played by the MEK/ERK/EGR-1 pathway in orthopoxviruses vaccinia and cowpox biology.

Patrícia N G Silva1, Jamária A P Soares, Bruno S A F Brasil, Sarah V Nogueira, Anderson A Andrade, José C de Magalhães, Marisa B Bonjardim, Paulo C P Ferreira, Erna G Kroon, Oscar Bruna-Romero, Cláudio A Bonjardim.   

Abstract

Appropriation of signalling pathways facilitates poxvirus replication. Poxviruses, as do most viruses, try to modify the host cell environment to achieve favourable replication conditions. In the present study, we show that the early growth response 1 gene (egr-1) is one of the host cell factors intensely modulated by the orthopoxviruses VV (vaccinia virus) and CPV (cowpox virus). These viruses stimulated the generation of both egr-1 mRNA and its gene product, throughout their entire replication cycles, via the requirement of MEK [mitogen-activated protein kinase/ERK (extracellular-signal-regulated kinase) kinase]/ERK pathway. We showed that, upon VV infection, EGR-1 translocates into the nucleus where it binds to the EBS (egr-1-binding site) positioned at the 5' region of EGR-1-regulated genes. In spite of both viruses belonging to the same genus, several lines of evidence, however, revealed a remarkable contrast between them as far as the roles played by the MEK/ERK/EGR-1 pathway in their biological cycles are concerned. Hence (i) the knocking-down of egr-1 by siRNA (small interfering RNA) proved that this transcription factor is of critical relevance for VV biology, since a decrease of about one log cycle in virus yield was verified, along with a small virus plaque phenotype, whereas the gene silencing did not have a detrimental effect on either CPV multiplication or viral plaque size; (ii) while both pharmacological and genetic inhibition of MEK/ERK resulted in a significant decrease in VV yield, both approaches had no impact on CPV multiplication; and (iii) CPV DNA replication was unaffected by pharmacological inhibition of MEK/ERK, but phosphorylation of MEK/ERK was dependent on CPV DNA replication, contrasting with a significant VV DNA inhibition and VV DNA replication-independence to maintain ERK1/2 phosphorylation, observed under the same conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16686604      PMCID: PMC1525012          DOI: 10.1042/BJ20060509

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

1.  Entry of the two infectious forms of vaccinia virus at the plasma membane is signaling-dependent for the IMV but not the EEV.

Authors:  J K Locker; A Kuehn; S Schleich; G Rutter; H Hohenberg; R Wepf; G Griffiths
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

2.  A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.

Authors:  A Bowie; E Kiss-Toth; J A Symons; G L Smith; S K Dower; L A O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

3.  Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines.

Authors:  T Nilsson; H Zetterberg; Y C Wang; L Rymo
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Characterization of a vaccinia-like virus isolated in a Brazilian forest.

Authors:  Flávio G da Fonseca; Giliane S Trindade; Ricardo L A Silva; Cláudio A Bonjardim; Paulo C P Ferreira; Erna G Kroon
Journal:  J Gen Virol       Date:  2002-01       Impact factor: 3.891

5.  Induction of sequence-specific binding of Drosophila heat shock activator protein without protein synthesis.

Authors:  V Zimarino; C Wu
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

6.  Transcription factor YY1 is a vaccinia virus late promoter activator.

Authors:  S S Broyles; X Liu; M Zhu; M Kremer
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

7.  Use of chemokine receptors by poxviruses.

Authors:  A S Lalani; J Masters; W Zeng; J Barrett; R Pannu; H Everett; C W Arendt; G McFadden
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

8.  A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication.

Authors:  J C de Magalhães; A A Andrade; P N Silva; L P Sousa; C Ropert; P C Ferreira; E G Kroon; R T Gazzinelli; C A Bonjardim
Journal:  J Biol Chem       Date:  2001-07-17       Impact factor: 5.157

9.  HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter.

Authors:  Yili Yang; Bei Dong; Paul R Mittelstadt; Hua Xiao; Jonathan D Ashwell
Journal:  J Biol Chem       Date:  2002-03-21       Impact factor: 5.157

10.  Molecular chaperone Hsp90 is important for vaccinia virus growth in cells.

Authors:  Jan-Jong Hung; Che-Sheng Chung; Wen Chang
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

View more
  20 in total

1.  Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.

Authors:  Ossie F Dyson; Christopher M Traylen; Shaw M Akula
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

2.  A vaccinia virus-driven interplay between the MKK4/7-JNK1/2 pathway and cytoskeleton reorganization.

Authors:  Anna C T C Pereira; Flávia G G Leite; Bruno S A F Brasil; Jamaria A P Soares-Martins; Alice A Torres; Paulo F P Pimenta; Thaïs Souto-Padrón; Paula Traktman; Paulo C P Ferreira; Erna G Kroon; Cláudio A Bonjardim
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

3.  Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter.

Authors:  Luca Romagnoli; Ilker K Sariyer; Jacqueline Tung; Mariha Feliciano; Bassel E Sawaya; Luis Del Valle; Pasquale Ferrante; Kamel Khalili; Mahmut Safak; Martyn K White
Journal:  Virology       Date:  2008-03-18       Impact factor: 3.616

4.  Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication.

Authors:  Jamária A P Soares; Flávia G G Leite; Luciana G Andrade; Alice A Torres; Lirlândia P De Sousa; Lucíola S Barcelos; Mauro M Teixeira; Paulo C P Ferreira; Erna G Kroon; Thaís Souto-Padrón; Cláudio A Bonjardim
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

5.  Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis.

Authors:  Gilad Sivan; Scott E Martin; Timothy G Myers; Eugen Buehler; Krysia H Szymczyk; Pinar Ormanoglu; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

6.  Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6 gene.

Authors:  Kaoru Inoue; Masahiko Negishi
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

7.  Impact of methoxyacetic acid on mouse Leydig cell gene expression.

Authors:  Gargi Bagchi; Yijing Zhang; David J Waxman
Journal:  Reprod Biol Endocrinol       Date:  2010-06-18       Impact factor: 5.211

8.  Lytic HSV-1 infection induces the multifunctional transcription factor Early Growth Response-1 (EGR-1) in rabbit corneal cells.

Authors:  Gautam R Bedadala; Jayavardhana R Palem; Lorna Graham; James M Hill; Harris E McFerrin; Shao-Chung Hsia
Journal:  Virol J       Date:  2011-05-27       Impact factor: 4.099

9.  Comparison of host cell gene expression in cowpox, monkeypox or vaccinia virus-infected cells reveals virus-specific regulation of immune response genes.

Authors:  Daniel Bourquain; Piotr Wojtek Dabrowski; Andreas Nitsche
Journal:  Virol J       Date:  2013-02-20       Impact factor: 4.099

10.  Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.

Authors:  Julie Delaloye; Thierry Roger; Quynh-Giao Steiner-Tardivel; Didier Le Roy; Marlies Knaup Reymond; Shizuo Akira; Virginie Petrilli; Carmen E Gomez; Beatriz Perdiguero; Jürg Tschopp; Giuseppe Pantaleo; Mariano Esteban; Thierry Calandra
Journal:  PLoS Pathog       Date:  2009-06-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.